EFDID: 439290EFD: View Filing

Issuer: Cancer IQ Inc. (0001810038) - D

Accession: 0001810038-22-000005 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001810038
  • Entity Name:
    Cancer IQ Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    515 N. STATE STREET
    SUITE 1025
    CHICAGO, IL 60654
  • Persons:
    Related Persons 5
    Olufeyikemi Olopade Ayodele
    Executive Officer, Director
    Mark Bakken
    Director
    Haibo Lu
    Executive Officer, Director
    Andrea Metkus
    Director
    Joel Krikston
    Director
EDGAR: Offering Information
  • Accession Date:
    04/07/2022
  • First Sale Date:
    03/02/2022
  • Offering Amount:
    $14,000,293
  • Amount Sold:
    $14,000,293
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, MA, NJ, NY, TX, WI
Inactive:IL, WA
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
B. C. Ziegler and Company 61 None None CA, IL, MA, NJ, NY, TX, WA, WI
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Cancer IQ Inc.Olufeyikemi Olopade AyodeleOlufeyikemi Olopade AyodelePresident & CEO2022-03-16